Fractal delivers its first ever $100 million revenue quarter, reports EBITDA growth of 71% YoY

Fractal's Q2 net income surged 139% on broad-based 20% revenue growth.

What the company is saying

Fractal Analytics Ltd (BSE:544700, NSE:FRACTAL) is emphasizing a dramatic improvement in profitability and strong revenue momentum for Q2 FY27, ending September 30, 2026. The company highlights consolidated operating revenue of INR 9,565 million, up 20% year on year, and net income of INR 792 million, up 139% YoY. Management attributes this growth to robust performance in Healthcare and Life Sciences (79% YoY growth) and BFSI (30% YoY), with the Consumer Packaged Goods and Retail vertical also contributing (11% YoY). The announcement stresses the success of Fractal's AI products, notably Cogentiq, which reached an annual revenue run-rate of over INR 1,500 million, up 39% YoY. CEO Srikanth Velamakanni frames the results as evidence of Fractal's readiness for an AI-driven future, stating that revenue crossed $100 million and net income more than doubled. The company also draws attention to operational metrics: Net Revenue Retention at 115%, NPS at 76, and an adjusted EBITDA margin of 16%, up 123 basis points YoY. The tone is confident, with a focus on realized financial results and the company's ongoing investment in AI R&D.

What the data suggests

The disclosed figures show Fractal delivered consolidated operating revenue of INR 9,565 million in Q2 FY27, a 20% year-on-year increase (10% in constant currency). Net income jumped 139% YoY to INR 792 million, indicating a significant margin expansion. Adjusted EBITDA margin improved by 123 basis points to 16%. Revenue growth was strongest in Healthcare and Life Sciences (79% YoY), followed by BFSI (30% YoY), CPGR (11% YoY), and TMT (6% QoQ). Fractal's product suite, including Cogentiq, achieved an annual revenue run-rate exceeding INR 1,500 million, up 39% YoY. Net Revenue Retention stood at 115%, reflecting increased client spend, while NPS reached 76. The company employs over 6,000 professionals and invests more than 6% of revenue in AI R&D. The results are supported by hard financial data, with management attributing growth to sectoral outperformance and increased product traction. Claims about strategic initiatives and product benchmarks (IndiaAI Mission, Vaidya.ai) are not supported by additional quantitative evidence in this release.

Analysis

The announcement from Fractal Analytics Ltd is overwhelmingly supported by realised, measurable financial and operational data. The company discloses consolidated operating revenue (INR 9,565 million, +20% YoY), net income (+139% YoY), adjusted EBITDA margin (16%, +123bps YoY), and detailed vertical growth rates, all for the most recent quarter. These are hard, realised facts, not projections. Only a small portion of the language is forward-looking, and these statements are general and do not inflate near-term expectations. The capital intensity flag is not triggered, as R&D investment is a modest percentage of revenue and is already being expensed. There is no evidence of narrative inflation: the tone is positive but proportionate to the strong results. The only minor unsupported claims relate to qualitative statements about product achievements and strategic initiatives, but these do not materially affect the overall signal.

Risk flags

• ●Sustaining high growth rates in Healthcare and Life Sciences (79% YoY) and BFSI (30% YoY) may be challenging as these sectors mature, potentially leading to slower growth in future quarters if market saturation or competitive pressures increase.
• ●The company's ongoing investment in AI R&D (over 6% of revenue) is necessary for innovation but could pressure margins if revenue growth slows or if R&D projects do not yield commercially viable products.
• ●While Net Revenue Retention is strong at 115%, continued expansion depends on maintaining high client satisfaction and competitive differentiation in a rapidly evolving AI market, where client needs and technology standards can shift quickly.
• ●Some strategic claims, such as selection for the IndiaAI Mission and product achievements like Vaidya.ai's benchmark scores, lack supporting quantitative detail, making it difficult to assess their true impact or likelihood of future revenue contribution.

Bottom line

Fractal Analytics Ltd delivered a standout Q2 FY27, with net income up 139% and revenue up 20% YoY, driven by exceptional growth in Healthcare and BFSI verticals. The company's product-led strategy is gaining traction, as seen in a 39% YoY increase in annualized product revenue and robust Net Revenue Retention of 115%. Operational execution is strong, with margin expansion and high client satisfaction (NPS 76). While the financial results are credible and well-supported, some strategic claims lack detail, and sustaining current growth rates may become more difficult as the business scales. Investors should focus on whether Fractal can maintain this momentum, convert R&D investment into new revenue streams, and provide more granular updates on high-profile initiatives like the IndiaAI Mission. The most important takeaway is that Fractal's core business is accelerating, but continued outperformance will require both execution and transparency on emerging projects.

Announcement summary

(BSE:544700, NSE:FRACTAL) Fractal Analytics Ltd announced its consolidated financial results for Q2 FY27, ending September 30, 2026. The company reported consolidated operating revenue of INR 9,565 million, representing a 20% year-on-year (YoY) growth and 10% growth in constant currency terms YoY. Revenue growth was led by the Healthcare and Life Sciences (HLS) industry, which achieved 79% growth YoY. The Banking, Financial Services and Insurance (BFSI) vertical grew 30% YoY in Q2. The Consumer Packaged Goods and Retail (CPGR) vertical, Fractal's largest, grew 11% YoY. The Technology, Media, and Telecom (TMT) vertical saw 6% quarter-on-quarter (QoQ) growth. Fractal's products, including the Cogentiq agentic AI platform, reached an annual revenue run-rate of over INR 1,500 million, up 39% YoY. The company's Net Revenue Retention was 115% in Q2. The Net Promoter Score (NPS) during the period was 76. Adjusted EBITDA Margin expanded by 123 basis points YoY to 16%. Net Income grew 139% YoY to INR 792 million. Srikanth Velamakanni, Co-founder and Group CEO of Fractal, commented that AI models are becoming more capable and affordable, and that Fractal is preparing for a future where AI-driven decision-making is essential. He highlighted that revenue crossed $100 million and net income more than doubled. Fractal employs over 6,000 professionals across North America, EMEA, and Asia-Pacific. The company invests more than 6% of its revenue in AI R&D. Fractal was selected under the IndiaAI Mission to build a large reasoning model for India. Its models and products include Vaidya.ai, with the Vaidya 2.0 model being the first to score above 50 on OpenAI's HealthBench (hard), and PiEvolve. Fractal also incubated and spun out Qure.ai, a global healthcare AI leader. Other businesses include Asper.ai, a Revenue Growth Management product for CPG companies, and Analytics Vidhya, an Ed-tech platform.

Disagree with this article?